Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study.
Saved in:
| Title: | Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study. |
|---|---|
| Authors: | Ford CC; Department of Neurology, University of New Mexico Health Sciences Center, The University of New Mexico, Albuquerque, NM, USA., Cohen JA; Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA., Goodman AD; Department of Neurology, University of Rochester, Rochester, NY, USA., Lindsey JW; Department of Neurology, University of Texas Health Science Center at Houston (UTHouston), Houston, TX, USA., Lisak RP; Department of Neurology and Department of Biochemistry, Microbiology and Immunology, School of Medicine, Wayne State University, Detroit, MI, USA., Luzzio C; Departments of Neurology and Engineering, University of Wisconsin-Madison, Madison, WI, USA., Pruitt A; Department of Neurology, University of Pennsylvania Medical Center, Philadelphia, PA, USA., Rose J; Imaging and Neuroscience Center, School of Medicine, The University of Utah, Salt Lake City, UT, USA., Rus H; Department of Neurology, School of Medicine, University of Maryland, Baltimore, MD, USA., Wolinsky JS; Department of Neurology, University of Texas Health Science Center at Houston (UTHouston), Houston, TX, USA., Kadosh SE; Innovative Research and Development, Teva Pharmaceuticals, Netanya, Israel., Bernstein-Hanlon E; Global Clinical Programming, Teva Pharmaceuticals, Netanya, Israel., Stark Y; Global Clinical Development, Teva Pharmaceuticals, Netanya, Israel., Alexander JK; Global Medical Affairs, Teva Pharmaceuticals, West Chester, PA, USA/Jazz Pharmaceuticals, Palo Alto, CA, USA. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2022 Oct; Vol. 28 (11), pp. 1729-1743. Date of Electronic Publication: 2022 Jun 29. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-0970 |
|---|---|
| DOI: | 10.1177/13524585221094239 |
